16/06/2020
It is our pleasure to share the news that the Technion – Israel Institute of Technology and Rambam Health Care Campus have established a joint fund for research in human health. The fund will be directed towards the development of new therapies, rapid diagnostics, technologies that protect medical staff, innovations in healthcare and more. These interdisciplinary projects will bring together physicians, engineers and scientists in collaborative research.
This fund is a joint initiative of Technion President Professor Uri Sivan and Rambam General Director Dr. Michael Halberthal, and is a direct result of the strong partnership between our two institutions – a partnership that intensified during the recent COVID-19 outbreak in Israel. As part of the cooperation during this period, joint research was carried out by Technion researchers and Rambam medical teams. These collaborations yielded innovative developments that have already had an impact on treating patients, reducing infection, and protecting medical staff.
In recent months, the world has faced a health crisis that has affected all areas of life. A crisis of such proportions also presents opportunities. In our case, the situation boosted the joint collaboration between physicians, researchers, inventors, and engineers in their shared fight to curb COVID-19, and was based on a longstanding partnership between Rambam and the Technion. This is how connections and solutions were created for all aspects of diagnostics and therapeutics during this crisis – this is the strength of our partnership.
Please contact us for further information on how you could become a part of this incredible initiative.
